| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |